scispace - formally typeset
Journal ArticleDOI

Antineoplastic agents, 122. Constituents of Combretum caffrum.

TLDR
An investigation of the South African tree Combretum caffrum (Combretaceae) for antineoplastic constituents was conducted by employing the astrocytoma bioassay (9ASK) and a substance designated combretastatin was isolated and found to display significant astroCyte reversal and murine P-388 lymphocytic leukemia cell growth inhibition.
Abstract
An investigation of the South African tree Combretum caffrum (Combretaceae) for antineoplastic constituents was conducted by employing the astrocytoma bioassay (9ASK). By this approach and a combination of solvent partition, steric exclusion, and adsorption chromatographic procedures, a substance designated combretastatin [1a] was isolated and found to display significant (71-90% astrocyte reversal at 1-100 micrograms/ml dose levels) astrocyte reversal and murine P-388 lymphocytic leukemia (PS) cell growth inhibition (ED50 0.011 micrograms/ml). The structure of (-)-combretastatin was elucidated by X-ray crystal structure analysis and confirmed by total synthesis. The absolute configuration at C-10 was assigned the R-configuration on the basis of Horeau esterification techniques. Other prominent, albeit PS-inactive, constituents were found to be 3,3',4'-tri-O-methylellagic acid [2] and acacetin [3].

read more

Citations
More filters
Journal ArticleDOI

Disrupting tumour blood vessels

TL;DR: A full understanding of the action of tubulin-binding combretastatins and other VDAs will provide insights into mechanisms that control tumour blood flow and will be the basis for the development of new therapeutic drugs for targeting the established tumour vasculature for therapy.
Journal ArticleDOI

Natural stilbenes: an overview

TL;DR: From January 1995 to the end of 2008, more than 400 new naturally occurring stilbenes were isolated and identified, and this review focuses on their structural diversity, distribution, and bioactivity.
Journal ArticleDOI

The biology of the combretastatins as tumour vascular targeting agents

TL;DR: The current understanding of the mechanism of action of the combretastatins and their therapeutic potential is reviewed.
Journal ArticleDOI

Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids

TL;DR: A detailed account of the design strategies employed for the synthesis of anticancer agents via molecular hybridization techniques is offered and the structure activity relationship along with mechanistic insights revealed during the biological evaluation of the hybrids are highlighted.
Journal ArticleDOI

Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies.

TL;DR: Despite causing profound damage to tumours, VDAs fail to halt tumour growth unless used together with conventional treatments, and the focus is now to understand mechanisms of susceptibility and resistance to identify novel molecular targets and develop strategies that are more effective.
Related Papers (5)